ADVFN US – Market Content Editor

  • Nvidia tops Q2 expectations, but China restrictions weigh on data center revenue

    Nvidia tops Q2 expectations, but China restrictions weigh on data center revenue

    Nvidia delivered stronger-than-expected second-quarter results on Wednesday, though revenue from its data center business came in just shy of forecasts as U.S. limits on H20 chip exports to China took a toll. Shares of NVIDIA Corporation (NASDAQ:NVDA) slipped roughly 2% in after-hours trading following the release. For the quarter ending July 31, the chipmaker posted…

  • S&P 500 Edges Up To Record Closing High Ahead Of Nvidia Earnings

    S&P 500 Edges Up To Record Closing High Ahead Of Nvidia Earnings

    After ending yesterday’s choppy trading session mostly higher, stocks saw some further upside during trading on Wednesday. While buying interest was somewhat subdued, the S&P 500 managed to reach a new record closing high. The major averages all posted modest gains on the day. The Dow rose 147.16 points or 0.3 percent to 45,565.23, the…

  • Krispy Kreme shares downgraded to sell by JPMorgan amid turnaround execution risks

    Krispy Kreme shares downgraded to sell by JPMorgan amid turnaround execution risks

    JPMorgan lowered its rating on Krispy Kreme (NASDAQ:DNUT) to Underweight from Neutral, citing uncertainty around the company’s turnaround plan and weakening U.S. business trends. In a note, the analysts said they continue “to not publish a price target,” emphasizing that the stock has dropped from its July 2021 IPO price of $17 to roughly $3.73…

  • Rexford Industrial Realty shares surge after Elliott stake disclosure

    Rexford Industrial Realty shares surge after Elliott stake disclosure

    Rexford Industrial Realty (NYSE:REXR) shares climbed more than 5% on Wednesday following a Bloomberg report indicating that activist investor Elliott Investment Management has acquired a significant stake in the Los Angeles-based real estate investment trust. Sources familiar with the situation said that Elliott’s holding positions it among Rexford’s top five shareholders, although the hedge fund’s…

  • Greenwave shares dip after receiving another Nasdaq delinquency notice

    Greenwave shares dip after receiving another Nasdaq delinquency notice

    Greenwave Technology Solutions Inc (NASDAQ:GWAV) stock fell 2.3% in Wednesday premarket trading after the metal recycling firm received an additional delinquency notice from Nasdaq for not submitting required financial reports on time. The company disclosed that it received this notice on August 22, 2025, regarding its delay in filing the Quarterly Report on Form 10-Q…

  • Azitra shares surge after first patient receives ATR04-484 in Phase 1/2 trial

    Azitra shares surge after first patient receives ATR04-484 in Phase 1/2 trial

    Azitra Inc (AMEX:AZTR) stock jumped 67% in premarket trading Wednesday following the announcement that the first patient has been dosed in the Phase 1/2 trial for ATR04-484, a potential treatment for EGFR inhibitor-associated rash. The candidate, a topical live biotherapeutic, aims to treat a condition affecting roughly 150,000 people annually in the U.S. It has…

  • BeOne Medicines shares dip after EU greenlights TEVIMBRA for lung cancer

    BeOne Medicines shares dip after EU greenlights TEVIMBRA for lung cancer

    BeOne Medicines AG (NASDAQ:ONC) stock fell 3.2% following the European Commission’s approval of TEVIMBRA (tislelizumab) for treating resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. The approval stems from the Phase 3 RATIONALE-315 trial, which showed that TEVIMBRA combined with platinum-based chemotherapy before surgery, followed by TEVIMBRA monotherapy, provided a statistically significant…

  • Vor Biopharma shares rise after collaborator’s IgAN therapy meets Phase 3 endpoint

    Vor Biopharma shares rise after collaborator’s IgAN therapy meets Phase 3 endpoint

    Vor Biopharma Inc (NASDAQ:VOR) saw its stock climb 2.9% following news that its partner RemeGen Co., Ltd (USOTC:REGMY) successfully hit the primary endpoint in Stage A of a Phase 3 trial for telitacicept in adults with IgA nephropathy (IgAN). The China-based study reported a 55% reduction in 24-hour urine protein-to-creatinine ratio (UPCR) at 39 weeks…

  • Williams-Sonoma beats Q2 forecasts, lifts revenue guidance

    Williams-Sonoma beats Q2 forecasts, lifts revenue guidance

    Williams-Sonoma, Inc. (NYSE:WSM) surpassed analyst expectations for its second-quarter results, reporting adjusted earnings per share of $2.00, above the consensus estimate of $1.78. Quarterly revenue reached $1.84 billion, exceeding forecasts of $1.82 billion. The home goods retailer achieved comparable brand revenue growth of 3.7% year-over-year, with all brands posting positive comparable sales. Its operating margin…

  • DevvStream shares surge after regaining Nasdaq compliance

    DevvStream shares surge after regaining Nasdaq compliance

    DevvStream Corp. (NASDAQ:DEVS) saw its stock jump 31.6% in premarket trading Wednesday following news that the carbon management company has restored compliance with Nasdaq’s minimum bid price rule. The firm received notification from Nasdaq on August 22, 2025, confirming it met the exchange’s listing standards. Previously, DevvStream’s shares had traded below the $1.00 minimum bid…